Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma
View/ Open
Date
2022Author
Şahin, Eda AdeviyeToprak, Serhat
Sayal, Hasan Berkan
Ekinci, Tekin
Yılmaz, Ercan
Bakay, Kadir
Melekoğlu, Rauf
Sezgin, Burak
Tohma, Yusuf Aytaç
Şahin, Hanifi
Metadata
Show full item recordCitation
Sahin, EA, Toprak, S, Sayal, HB, et al. Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma. Int J Gynecol Obstet. 2022; 00: 1- 8. doi: 10.1002/ijgo.14277Abstract
Objective To investigate the prognostic factors of patients with Grade 3 endometrioid endometrial cancer (G3EEC). Methods This four-center, retrospective study included a total of 129 women with G3EEC. Demographic, clinicopathologic, and survival data were collected. Kaplan-Meier method was used for survival analysis. Predictors of outcome were analyzed using Cox proportional hazards models. Results Median age at the time of diagnosis was 63 (range 39-87) years and median follow up was 37 (range 6-126) months. For the entire cohort, the 5-year disease-free survival (DFS) and overall survival (OS) were 54.3% and 63.6%, respectively. The 5-year DFS rates for lymphovascular space invasion (LVSI) -positive and -negative patients were 41.6% and 88.3%, respectively (P < 0.001). The 5-year OS rates for LVSI-positive and -negative patients were 54.7% and 88.3%, respectively (P = 0.001). Positive LVSI status was identified as the independent prognostic factor for decreased DFS and OS (hazard ratio [HR] 5.5, 95% confidence interval [CI] 1.65-18.86; P = 0.006 versus HR 4.4, 95% CI 1.33-14.58; P = 0.013, respectively). Conclusion LVSI seems to be an independent prognostic factor for decreased DFS and OS in G3EEC patients.